The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy

OBJECTIVE: To investigate the clinical efficacy and safety of dapagliflozin in the treatment of diabetic nephropathy (DN). METHODS: A total of 120 DN patients admitted to our hospital from June 2017 to March 2020 were divided into control and experimental groups, with 60 cases in each group. The con...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ying, Lu, Wen, Lu, Hongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966174/
https://www.ncbi.nlm.nih.gov/pubmed/35351189
http://dx.doi.org/10.1186/s13098-022-00815-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966174/
https://www.ncbi.nlm.nih.gov/pubmed/35351189
http://dx.doi.org/10.1186/s13098-022-00815-y

Ejemplares similares